An Added Punch to Combat Seizures
As some who suffer with it know, epilepsy can be difficult. The fear of seizures can itself be exhausting.
Some Hope for Tough Epilepsy Cases
Epilepsy patients can suffer from a variety of symptoms; it's not just about seizures. A drug offers hope for many quality of life improvements, but may pose risks for some patients.
Treating Epilepsy While Pregnant
It has been well established that there is a risk of birth defects in the baby for pregnant women taking the anti-seizure medication phenytoin . Newer anti-epileptic drugs are safer, and a new study aimed to confirm the data.
Certain Seizure Meds Safer Than Others
There are a number of medications used to treat epilepsy. Some of these anti-seizure medications have been shown to increase heart disease risks. New research shows epilepsy patients may have safer choices.
Epilepsy Drug Linked to Autism
The exact causes of autism are still not known, and much of how the disorder develops remain a mystery. Many studies point to prenatal development links.
FDA approves Onfi to treat severe type of seizures
On Oct. 21, the U.S. Food and Drug Administration approved Onfi tablets ( clobazam ) for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older.
Which Is Best, Surgery Or Medication?
Some forms of epilepsy are tough to treat with just a medication. A new study demonstrates that brain surgery is a viable alternative to medication therapies.
Hyperventilating May Cause Childhood Seizures
Pediatricians are very focused on their patients avoiding extended high fevers for many health reasons. One of their concerns is that fevers can cause a febrile seizure.
New View of Vitamin C
Vitamin C has long been touted as a super antioxidant. Maybe you've even taken some at the first sign of cold. Now scientists are finding that vitamin C offers a surprising benefit.
Epilepsy Drug Trial May Have Been Sales Tactic
Yale School of Medicine researchers have discovered that a clinical trial of epilepsy drug gabapentin (trade name Neurontin) may have actually been a promotional and sales move to increase prescriptions of the medicine.